Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

Breast cancer risk assessment using genetic variants and risk factors in a Singapore Chinese population.

Lee CP, Irwanto A, Salim A, Yuan JM, Liu J, Koh WP, Hartman M.

Breast Cancer Res. 2014 Jun 18;16(3):R64. [Epub ahead of print]

PMID:
24941967
[PubMed - as supplied by publisher]
Free PMC Article
2.

Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis.

Fasching PA, Ekici AB, Wachter DL, Hein A, Bayer CM, Häberle L, Loehberg CR, Schneider M, Jud SM, Heusinger K, Rübner M, Rauh C, Bani MR, Lux MP, Schulz-Wendtland R, Hartmann A, Beckmann MW.

Geburtshilfe Frauenheilkd. 2013 Dec;73(12):1228-1235.

PMID:
24771903
[PubMed]
Free PMC Article
3.

Distribution of BRCA1 and BRCA2 Mutations in Asian Patients with Breast Cancer.

Kim H, Choi DH.

J Breast Cancer. 2013 Dec;16(4):357-65. doi: 10.4048/jbc.2013.16.4.357. Epub 2013 Dec 31. Review.

PMID:
24454456
[PubMed]
Free PMC Article
4.

The korean hereditary breast cancer study: review and future perspectives.

Kang E, Kim SW.

J Breast Cancer. 2013 Sep;16(3):245-53. doi: 10.4048/jbc.2013.16.3.245. Epub 2013 Sep 30. Review.

PMID:
24155753
[PubMed]
Free PMC Article
5.

Breast cancer in the young: role of the geneticist.

Woodson AH, Profato JL, Muse KI, Litton JK.

J Thorac Dis. 2013 Jun;5(Suppl 1):S19-26. doi: 10.3978/j.issn.2072-1439.2013.04.13.

PMID:
23819023
[PubMed]
Free PMC Article
6.

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.

Weitzel JN, Clague J, Martir-Negron A, Ogaz R, Herzog J, Ricker C, Jungbluth C, Cina C, Duncan P, Unzeitig G, Saldivar JS, Beattie M, Feldman N, Sand S, Port D, Barragan DI, John EM, Neuhausen SL, Larson GP.

J Clin Oncol. 2013 Jan 10;31(2):210-6. doi: 10.1200/JCO.2011.41.0027. Epub 2012 Dec 10. Erratum in: J Clin Oncol. 2013 May 1;31(13):1702.

PMID:
23233716
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers.

Mazzola E, Cheng SC, Parmigiani G.

Breast Cancer Res Treat. 2013 Jan;137(1):315-8. doi: 10.1007/s10549-012-2345-5. Epub 2012 Nov 27.

PMID:
23184082
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

A focus group study on breast cancer risk presentation: one format does not fit all.

Dorval M, Bouchard K, Chiquette J, Glendon G, Maugard CM, Dubuisson W, Panchal S, Simard J.

Eur J Hum Genet. 2013 Jul;21(7):719-24. doi: 10.1038/ejhg.2012.248. Epub 2012 Nov 21.

PMID:
23169493
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.

Quante AS, Whittemore AS, Shriver T, Strauch K, Terry MB.

Breast Cancer Res. 2012 Nov 5;14(6):R144. doi: 10.1186/bcr3352.

PMID:
23127309
[PubMed - in process]
Free PMC Article
10.

Sequence Variants of BRCA1 and BRCA2 Genes in Four Iranian Families with Breast and Ovarian Cancer.

Keshavarzi F, Noughani AE, Ayoubian M, Zeinali S.

Iran J Public Health. 2011;40(2):57-66. Epub 2011 Jun 30.

PMID:
23113073
[PubMed]
Free PMC Article
11.

BRCA1 R1699Q variant displaying ambiguous functional abrogation confers intermediate breast and ovarian cancer risk.

Spurdle AB, Whiley PJ, Thompson B, Feng B, Healey S, Brown MA, Pettigrew C; kConFab, Van Asperen CJ, Ausems MG, Kattentidt-Mouravieva AA, van den Ouweland AM; Dutch Belgium UV Consortium, Lindblom A, Pigg MH, Schmutzler RK, Engel C, Meindl A; German Consortium of Hereditary Breast and Ovarian Cancer, Caputo S, Sinilnikova OM, Lidereau R; French COVAR group collaborators, Couch FJ, Guidugli L, Hansen Tv, Thomassen M, Eccles DM, Tucker K, Benitez J, Domchek SM, Toland AE, Van Rensburg EJ, Wappenschmidt B, Borg Å, Vreeswijk MP, Goldgar DE; ENIGMA Consortium.

J Med Genet. 2012 Aug;49(8):525-32.

PMID:
22889855
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A case-control study on risk factors of breast cancer in China.

Xu YL, Sun Q, Shan GL, Zhang J, Liao HB, Li SY, Jiang J, Shao ZM, Jiang HC, Shen NC, Shi Y, Yu CZ, Zhang BN, Chen YH, Duan XN, Li B.

Arch Med Sci. 2012 May 9;8(2):303-9. doi: 10.5114/aoms.2012.28558.

PMID:
22662004
[PubMed]
Free PMC Article
13.

Spatial analysis of county-level breast cancer mortality in Texas.

Bambhroliya AB, Burau KD, Sexton K.

J Environ Public Health. 2012;2012:959343. doi: 10.1155/2012/959343. Epub 2012 Jan 31.

PMID:
22518193
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Clinical software development for the Web: lessons learned from the BOADICEA project.

Cunningham AP, Antoniou AC, Easton DF.

BMC Med Inform Decis Mak. 2012 Apr 10;12:30. doi: 10.1186/1472-6947-12-30.

PMID:
22490389
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Efficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach.

Joseph G, Kaplan C, Luce J, Lee R, Stewart S, Guerra C, Pasick R.

Public Health Genomics. 2012;15(3-4):172-80. doi: 10.1159/000336419. Epub 2012 Apr 4.

PMID:
22488460
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Breast cancer risk assessment with five independent genetic variants and two risk factors in Chinese women.

Dai J, Hu Z, Jiang Y, Shen H, Dong J, Ma H, Shen H.

Breast Cancer Res. 2012 Jan 23;14(1):R17.

PMID:
22269215
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer.

Ståhlbom AK, Johansson H, Liljegren A, von Wachenfeldt A, Arver B.

Fam Cancer. 2012 Mar;11(1):33-40. doi: 10.1007/s10689-011-9495-1.

PMID:
22124624
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany.

Gadzicki D, Evans DG, Harris H, Julian-Reynier C, Nippert I, Schmidtke J, Tibben A, van Asperen CJ, Schlegelberger B.

J Community Genet. 2011 Jun;2(2):53-69. doi: 10.1007/s12687-011-0042-4. Epub 2011 Mar 2.

PMID:
22109790
[PubMed]
Free PMC Article
19.

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.

Kote-Jarai Z, Leongamornlert D, Saunders E, Tymrakiewicz M, Castro E, Mahmud N, Guy M, Edwards S, O'Brien L, Sawyer E, Hall A, Wilkinson R, Dadaev T, Goh C, Easton D; UKGPCS Collaborators, Goldgar D, Eeles R.

Br J Cancer. 2011 Oct 11;105(8):1230-4. doi: 10.1038/bjc.2011.383. Epub 2011 Sep 27.

PMID:
21952622
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.

Weitzel JN, Blazer KR, Macdonald DJ, Culver JO, Offit K.

CA Cancer J Clin. 2011 Aug 19. doi: 10.3322/caac.20128. [Epub ahead of print]

PMID:
21858794
[PubMed - as supplied by publisher]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk